|
|
GROUNDBREAKING NEWS |
|
At BioNTX, we are proud to spotlight key developments that reflect the strength, vision, and diversity of our region’s life science ecosystem. The stories below represent more than headlines—they highlight the pioneering research, breakthrough technologies, and bold entrepreneurs that make North Texas a uniquely powerful force in biotech and healthcare innovation. |
|
Nanoscope Sets New Benchmark with Historic FDA Submission for Vision-Restoring Therapy |
|
|
|
Nanoscope Therapeutics is advancing new hope for patients with severe vision loss, initiating its rolling Biologics License Application (BLA) submission to the FDA for MCO-010, the company’s groundbreaking gene-agnostic therapy for retinitis pigmentosa (RP), this is a life-changing breakthrough for those with limited or no treatment options today.
RP is a complex degenerative eye disease driven by more than 100 known genetic mutations, but Nanoscope’s approach bypasses more than genetic barriers.
This marks a major leap forward not only for RP patients, but for the broader fields of gene therapy and regenerative medicine. With fast-track designation and eligibility for priority review, the submission is on track for completion by early 2026.
|
|
Lantern Pharma Uses AI to Fast-Track Cancer Combination Treatments |
|
|
Lantern Pharma has launched an AI-powered module within its RADR® platform to predict the effectiveness of cancer drug combinations involving DNA-damaging agents (DDAs) and DNA damage response inhibitors (DDRis). Based on data from 221 clinical trials, the module supports faster, more precise development of targeted therapies. It has already guided an FDA-cleared Phase 1B/2 trial in triple-negative breast cancer (TNBC), combining LP-184 with olaparib, and represents a key step forward as the cancer combination therapy market nears $50 billion by 2030. |
|
Breaking New Ground in Women’s Health: Spark Biomedical Unveils OhmBody with Powerful Backing |
|
|
|
|
Spark Biomedical is redefining women’s wellness with the launch of OhmBody, a breakthrough wearable that addresses menstrual symptoms through advanced bioelectronic therapy.
OhmBody’s sleek, non-invasive earpiece uses precise vagus and trigeminal nerve stimulation to help reduce cramps, heavy bleeding, fatigue, and emotional swings — all without medication. It is a natural, science-driven solution that is already delivering impressive results:
With a $15 million Series A investment fueling its growth, Spark Biomedical is scaling its impact beyond women’s health to broader applications in neurological care. The $719 OhmBody Starter Kit includes the device, seven adhesive earpieces, a cable, and setup tools — providing women with an innovative, accessible way to manage their cycles naturally. This is more than a device. It is the beginning of a movement to transform the future of women’s health.
|
|
Vascular Company Finds New Home in North Texas |
|
|
One in three Americans over 45 suffers from vein disease, and treatment often involves bulky machines tethered to walls. Koya Medical changed that with the first portable solution—and now, they are bringing that innovation to North Texas.
Last month, the company relocated from California to Dallas, growing into a 35,000 square foot facility. Koya plans to hire 300–400 people across billing, engineering, supply chain, and HR. They’re not starting from zero: 20+ employees and their families have already made the move alongside CEO Andy Doraiswamy. |
|
EisnerAmper Report on New Federal Tax Cuts |
|
|
On July 4, 2025, the “One Big Beautiful Bill Act” (OBBBA) went into law. This sweeping Republican-backed legislation makes key provisions of the Tax Cuts and Jobs Act permanent while rolling back and fast-tracking the end of many tax credits introduced under the Inflation Reduction Act. Read EisnerAmper's Report on the full bill below. |
|
Alloy Therapeutics Future Founder Fellowship Launches in North Texas in Fall 2025 |
|
|
The Alloy Future Founder Fellowship will bring world-class faculty, speakers, and a global curriculum to DFW, spotlighting the region as a rising biotech hub. By engaging top scientific and venture leaders, the program plans to bolster North Texas's visibility among investors, founders, and institutions
Alloy Future Founder Fellows will lead two Biotech Startup Academy cohorts: Fall 2025 (October 2 - November 14) and Spring 2026 (TBD).
Each 7-week hybrid program will host a dynamic mix of researchers, faculty, students, postdocs, and industry professionals exploring or launching life science ventures. |
|
EVENT RECAP |
|
Driving Change in Chronic Disease Care: Good Days' National Symposium Inspires Action at ARPA-H Hub |
|
|
|
|
(left photo) Jen Peterson; (right photo from left to right) Clorinda Walley, Sulagna Bhattacharya, Jenny Ligon |
|
The National Luncheon Symposium, hosted by Good Days at the ARPA-H Hub in Dallas, brought together biotech leaders, innovators, and patient advocates for an inspiring conversation on the future of chronic disease care.
Each year, seven of the top 10 causes of death in the U.S. are due to chronic illness. That’s why Good Days leads the National Chronic Disease Day campaign every July 10. Chronic Disease Day unites patients, healthcare leaders, nonprofits, policymakers, and communities to raise awareness, expand access to care, and promote healthier lives.
Good Days, a national 501(c)(3) nonprofit, has been a lifeline for patients since 2003. The organization provides financial assistance for medications, transportation, lodging, and other costs associated with life-altering chronic conditions. With over 2 million grants awarded and more than $3 billion in financial assistance delivered, Good Days is a national leader in access to care.
The symposium served as a powerful reminder of the impact that collaboration and compassion can have in shaping a more accessible and innovative healthcare landscape. |
|
Health Wildcatters Ignites Next Phase of Innovation with New HW Venture Center at Pegasus Park |
|
|
|
(middle photo from left to right) Kelly Cloud, Jovelyn Castellanos, Hubert Zajicek, Lindsey Settles, Lili Clark |
|
We are thrilled to congratulate the Health Wildcatters on their recent ribbon cutting and the exciting expansion of their Dallas headquarters at Pegasus Park! This milestone marks a new chapter for one of the region’s most impactful healthcare accelerators, as they grow their footprint and continue fostering innovation in biotech, medtech, and digital health.
The expanded space, named The HW Venture Center, will serve as a dynamic hub for startups, investors, and life science leaders across North Texas. This state-of-the-art facility provides a collaborative environment designed to accelerate early-stage health startups by offering access to critical resources, mentorship, and networking opportunities. Congratulations on this well-deserved achievement. |
|
BioNTX Welcomes Korean Delegation to Pegasus Park to Explore Global Collaboration |
|
|
Eric Moore, Chief Communications Officer of BioNTX, recently welcomed a Korean delegation from Beyond the Specialism and Reliability (BSR), alongside Daniel Shin, President, and Brian Kim, Secretary General of the Korean American Chamber of Commerce North Texas (KACNTX), for a tour of BioLabs and Pegasus Park.
The visit reflects the growing interest in building international bridges between North Texas and Korea, especially in the areas of innovation, life sciences, and global trade. BioNTX is committed to facilitating these connections as part of its broader mission to position North Texas as a global innovation hub.
We look forward to continuing conversations with BSR and the Korean American Chamber to advance partnership opportunities that will benefit our region and beyond. |
|
eosera® Foundation Pitch Competition |
|
|
Elyse Stoltz Dickerson, CEO and co-founder of eosera®, knows the power of a strong pitch—her own entrepreneurial journey began after winning a pitch competition. Today, she’s paying that experience forward through the eosera® Pitch Competition™, hosted by the eosera® foundation. This annual event invites female entrepreneurs based in Texas to pitch their ventures for a chance to win a cash prize.
The eosera® foundation is committed to creating pathways for women to lead, innovate, and succeed. Through strategic support, mentorship, and funding, the foundation works to eliminate barriers and expand opportunities for women in business. Whether through pitch competitions, mentorship programs, or community initiatives, eosera® continues to inspire the next generation of women founders. |
|
BIONTX PRESENTS: COMING SOON |
|
Meet, Connect, and Grow: BioNTX Talent Network for Job Seekers August 20 - 21, 2025 |
|
|
The BioNTX Talent Network Meet & Greet is an opportunity for life science professionals and job seekers to connect, share industry insights, and build relationships that support career growth. Attendees will have the chance to network with peers and meet representatives from Catapult Solutions Group, a staffing firm dedicated to helping you navigate your job search and advance your career. |
|
Thank you for your support |
|
|
Explore, Connect, and Refresh with BioNTX Facilities Committee in Grapevine August 27, 2025 |
|
|
|
Join the BioNTX Facilities Advisory Committee for an afternoon of networking and refreshments at McMillan James Equipment Company’s state-of-the-art facility in Grapevine, TX.
|
|
Thank you for your support |
|
|
MEMBER SPOTLIGHT |
|
Regenerative & Aesthetic Medicine Leaders in North Texas |
|
|
TriCelX has launched a flagship clinic at The Star in Frisco focused on advanced regenerative therapies and biologics. The clinic integrates an ISO Level 7 cleanroom with on-site processing of autologous adipose tissue—enabling same-day, cell-based treatments for orthopedic and musculoskeletal conditions without traditional surgery.
Their LumineX division applies similar biologic innovations to aesthetics, offering minimally invasive facial and body treatments using growth factors and regenerative compounds. With applications ranging from civilian care to military medicine, TriCelX is combining clinical delivery and R&D to accelerate next-gen biologic therapies.
|
|
MEMBER NEWS |
|
Alpha Cognition to Reveal Breakthrough ZUNVEYL Findings at AAIC 2025 |
|
|
|
Alpha Cognition Inc. will present new clinical data on its galantamine prodrug, ZUNVEYL, at the Alzheimer’s Association International Conference from July 27–31, 2025. The data highlight ZUNVEYL’s bioequivalence to existing galantamine formulations and its consistent dose response.
ZUNVEYL aims to improve cognition with fewer side effects. The company is also developing ZUNVEYL combined with memantine for advanced Alzheimer’s and as a sublingual therapy for cognitive impairment from mild traumatic brain injury. |
|
Colossal Biosciences: The Real-Life Jurassic Park |
|
|
Jurassic World Rebirth may be thrilling audiences on screen — but behind the scenes, a real-life revolution is unfolding.
Colossal Biosciences, the bold biotech startup founded by Ben Lamm and renowned Harvard geneticist Dr. George Church, is doing what once seemed impossible: bringing extinct species back to life. From plans to revive the woolly mammoth and Tasmanian tiger to the stunning birth of genetically engineered dire wolf pups named Romulus and Remus — Colossal is making de-extinction a scientific fact, not fantasy. |
|
Baylor Scott & White to Open New Frisco Medical Center |
|
|
Baylor Scott & White Health is set to open a new medical center at PGA Parkway in Frisco, addressing the growing healthcare needs of North Texas. The facility will serve one of the fastest-growing regions in the U.S., providing advanced inpatient and emergency services, along with expanded digital care options.
The 40-acre campus features walking trails, green spaces, and community wellness events, blending high-quality care with a focus on prevention and whole-person health. A dedicated Center for Women and Infants will offer specialized support from prenatal care through postpartum, both onsite and virtually.
|
|
Cumming Group Ranks Top 10 in ENR Construction Management Lists |
|
|
Cumming Group has been ranked eighth on ENR’s Top 50 Construction Management Firms list, and tenth on both the Top 50 Program Management Firms and Top 100 Construction Management/Project Management-for-Fee Firms.
The firm’s continued rise in these industry benchmarks reflects its strong growth and performance across sectors. As the top-ranked pure-play firm, Cumming Group remains uniquely positioned to advocate solely for its clients' best interests. |
|
DFW Leads the Nation with Cutting-Edge Hybrid Firefighting Technology |
|
|
Dallas Fort Worth International Airport (DFW) has launched the Striker Volterra, a revolutionary hybrid Aircraft Rescue and Firefighting (ARFF) vehicle that dramatically boosts response speed, reduces emissions, and enhances firefighter safety. With lightning-fast acceleration and near-silent electric operation, this six-wheeled powerhouse cuts critical response times—potentially saving more lives and minimizing damage.
As one of the first airports nationwide to deploy this advanced technology, DFW is leading the way in sustainable, high-performance emergency response. The airport will add five more Volterra vehicles this year and is upgrading its ARFF stations to support this game-changing fleet. |
|
EisnerAmper’s Prosperity Recognized Among Top CPA Firms for Assets Under Management |
|
|
Prosperity, an EisnerAmper Company, has been recognized by Accounting Today as a top firm for assets under management in its 19th annual listing.
The ranking highlights the nation’s leading CPA financial planners based on their assets under management. Prosperity specializes in holistic wealth management, offering services such as financial planning, investment management, retirement design, estate planning, tax strategy, and business planning. |
|
JLL Recognized for Outstanding Ethics and Compliance Program |
|
|
JLL announced that it has earned the prestigious Compliance Leader Verification from Ethisphere, a global authority on defining and advancing ethical business standards. This recognition highlights JLL’s ongoing commitment to integrity and accountability, reinforcing its position as a leader in ethical business practices and a trusted partner across industries. |
|
Morgan Lewis Recognized for Excellence in LegalTech and Litigation Services |
|
|
Morgan Lewis has earned its first-ever rankings in the 2025 editions of Chambers’ specialist guides, which highlight the most innovative organizations in alternative legal services, litigation support, and LegalTech.
The firm’s eData team was ranked in Chambers NewLaw for Global-wide: Litigation Services and recognized in Chambers Litigation Support for USA-Nationwide: eDiscovery. Morgan Lewis was the only law firm ranked in this category, highlighting its strength in combining technology and strategic support in complex litigation. |
|
Polsinelli Recognized for Legal Innovation and Excellence |
|
|
Polsinelli has been recognized with multiple prestigious awards for its leadership in legal innovation from both BTI Consulting Group and IFLR. The firm was featured in the BTI Law Firm Innovation Icons 2025 guide, which highlights top firms excelling in key areas such as legal strategy, AI integration, client-focused solutions, and technology-enabled legal services.
In addition, Polsinelli earned top honors from IFLR’s Women in Business Law Awards, receiving both Innovative Firm of the Year and Emerging Technology Firm of the Year for North America. These awards underscore the firm’s ability to combine forward-thinking technology with deep legal expertise to meet evolving client needs. |
|
RSM Accelerates AI Strategy to Drive Innovation and Client Solutions |
|
|
RSM US LLP, a leading provider of assurance, tax, and consulting services for the middle market, is expanding its artificial intelligence strategy by integrating advanced agentic AI platforms across its operations. This initiative aims to enhance efficiency, foster innovation, and deliver faster, smarter solutions for clients.
As RSM prepares to complete a transatlantic merger, forming a multinational firm with 23,000 professionals across six countries, the combined effort strengthens its position as a global AI leader, transforming how it helps clients navigate complex challenges and seize new opportunities. |
|
Sheppard Mullin Ranks Among Top Law Firms for Healthcare |
|
|
Sheppard Mullin continues to solidify its position as a leading national law firm, earning a place among Vault’s prestigious Top 100 Law Firms in 2025. Notably, the firm ranked #15 in the highly competitive Healthcare Practice Area Prestige category, showcasing its deep expertise and influential work in health law, regulatory compliance, and life sciences.
The firm also distinguished itself as a top workplace, ranking #7 Best Law Firm to Work For, #9 for Overall Inclusion, and #18 for Best Summer Associate Programs. |
|
Sikich Named a Top MSP for Innovation and Growth in 2025 |
|
|
Sikich, a global technology-enabled professional services firm, has been recognized among the world’s top-performing managed service providers (MSPs) in the 2025 Channel Partners MSP 501 rankings. This prestigious list benchmarks MSPs based on key metrics such as above-industry-average revenue growth, recurring revenue, high-margin services, and innovation—especially in monetizing AI services.
Sikich’s technology offerings span AI, cloud, security, collaboration, networking, help desk, and remote monitoring and management—addressing evolving customer needs across industries. |
|
UNTHSC Nursing Leader Completes Prestigious Global Research Fellowship |
|
|
|
Robyn Remotigue, MPPA, CRA |
|
Robyn Remotigue, Executive Director of Research and Scholarship at UNTHSC’s College of Nursing, completed the 2025 NCURA Global Senior Level Fellowship at King’s College London. One of only 10 recipients worldwide, the fellowship fosters international collaboration in research administration.
During the two-week program, Remotigue connected with research leaders across King’s College, sharing UNTHSC’s mission and gaining insights into global research management practices to enhance UNTHSC’s operations. |
|
UTA Ranked for Excellence in Health, Sustainability, and Equity |
|
|
The University of Texas at Arlington has earned recognition in the 2025 Times Higher Education Impact Rankings for its continued progress in supporting the United Nations Sustainable Development Goals (SDGs). These goals aim to tackle pressing global challenges including poverty, inequality, health, education, and climate change.
This recognition highlights UT Arlington’s growing global impact and its continued leadership in driving sustainable progress through innovation, collaboration, and a long-standing dedication to building healthier, more resilient communities. |
|
UTD Launches New Master’s Program in AI for Biomedical Sciences |
|
|
The University of Texas at Dallas is launching a new Master of Science in Artificial Intelligence for Biomedical Sciences this fall, along with a related graduate certificate program. Approved by the Texas Higher Education Coordinating Board, the program is one of the first in the state to focus specifically on AI applications in biomedical science.
The new degree and certificate aim to meet growing workforce demands in data-driven health and medical fields, offering training that ranges from foundational programming to advanced AI applications in human health. |
|
UTSW Awards 2025 Beth Levine Prize to Dr. Andrea Ballabio |
|
|
|
Andrea Ballabio, MD |
|
UT Southwestern Medical Center has named Italian medical geneticist Andrea Ballabio, M.D., as the recipient of the 2025 Beth Levine, M.D. Prize in Autophagy Research.
The prize honors outstanding contributions to the field of autophagy and commemorates the legacy of the late Dr. Beth Levine, a leader in autophagy research.
Dr. Ballabio is internationally recognized for his work on lysosomes, the cellular structures responsible for waste processing and regulation of metabolism. His research has shed light on the molecular mechanisms underlying genetic diseases and contributed significantly to the field of cell biology. |
|
FUNDING & MENTORSHIP OPPORTUNITIES |
|
Funding Bold Ideas to Advance Duchenne Muscular Dystrophy Research Letter of Intent due July 25, 2025 |
|
|
The FY25 Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) is designed to spark bold, early-stage research with the potential to transform the landscape of Duchenne muscular dystrophy (DMD). This award supports high-risk, high-reward ideas that are conceptually innovative and could lead to groundbreaking discoveries or new research directions that significantly improve outcomes for individuals living with DMD. |
|
DARPA CoasterChase Application due August 28 2025 |
|
|
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals that leverage a novel understanding of the enteric nervous system as well as emerging neuromodulation technologies to selectively target neurons in the small intestine and alter the body’s stress response. The CoasterChase program aims to develop a multimodal, ingestible, sensing and stimulation platform for use in monitoring and modulating biomarkers of acute stress from within the small intestine. Proposed research should investigate innovative approaches that enable revolutionary advances in enteric neuromodulation and sensing, ingestible electronics, and modulation of the stress response. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice. |
|
NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) Application due September 9, 2025 |
|
|
The NIH Director’s Pioneer Award supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director’s Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund. |
|
Addressing Rare Diseases Topical PCORI Funding Announcement -- Cycle 3 2025 Letter of Intent due September 23, 2025 |
|
|
The Patient-Centered Outcomes Research Institute (PCORI) intends to issue a PCORI Funding Announcement (PFA) on August 12, 2025, seeking to fund high-quality, patient-centered comparative clinical effectiveness research (CER) studies that focus on rare diseases. This preannouncement provides potential applicants additional time to identify collaborators; obtain patient and stakeholder input on potential studies; and develop responsive, high-quality proposals. |
|
BARDA VITAL Hub - DEV Awards Application due September 26, 2025 |
|
|
The VITAL Hub seeks proposals for the development of innovative therapeutics solutions in alignment with BARDA’s mission to promote health security. Multi-use/platform technologies are preferred for this solicitation. Funding through this program can be used to demonstrate: Proof-of-concept for a BARDA-relevant use case for an existing platform technology |
|
Propionic Acidemia Foundation Application closes October 1, 2025 |
|
|
PAF is a non-profit organization whose primary mission is to help advance research devoted to finding treatments and a cure for propionic acidemia. By funding research, we aim to accelerate new knowledge, discovery, development and/or evaluation of therapeutics leading to better treatment and a cure for all individuals affected by PA.
Funding available for Research projects and Post-Doctoral Fellows Program. |
|
Fueling the Next Generation of Health Innovators Application closes March 6, 2026 |
|
|
The One Health Incubator is a dynamic partnership between the Innovation Hub and the Health Sciences Center, created to support researchers and technology startups in the life sciences sector. This collaborative platform combines institutional expertise to offer an ecosystem of incubation, mentorship, and strategic connections—tailored specifically for life science innovators.
Startups and researchers benefit from access to state-of-the-art facilities, specialized resources, and guidance from industry experts. The incubator helps accelerate the development and commercialization of innovative healthcare solutions while fostering valuable relationships with potential partners, investors, and mentors. |
|
NIH Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions Program ends January 8, 2027 |
|
|
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. |
|
iC³ SUMMIT NEWS & UPDATES |
|
Save The Date: September 2025 |
|
|
|
The iC³ Life Science Summit is an event that brings together leaders and innovators from the life sciences and healthcare sectors to discuss challenges, discover new opportunities, and drive transformation.
As we look ahead to the 2025 iC³ Life Science & Healthcare Innovation Summit, we are celebrating “10 Years and Beyond” with a focus on the cutting-edge intersection of biology, technology, and artificial intelligence (AI). This convergence is powering breakthroughs in precision medicine, biomanufacturing, and other fields shaping the future of healthcare. |
|
|
Dates Tuesday, September 16: 7:00am - 7:00pm Wednesday, September 17: 8:00am - 3:30pm |
|
Location Hilton Anatole 2201 N Stemmons Freeway, Dallas, TX 75207 |
|
Applications Now Open for the 4th Annual Tech Transfer Showcase at BioNTX's iC³ Life Science Summit Application closes on July 28, 2025 |
|
Present your groundbreaking innovations at the 4th Annual Tech Transfer Showcase during BioNTX's iC³ Life Science Summit, an exclusive platform designed to connect academic institutions from Texas, Arkansas, Louisiana, New Mexico, Oklahoma, and Tennessee with top industry leaders and investors.
This event offers a unique opportunity to highlight your most promising intellectual property, explore potential collaborations, and secure funding, all while advancing the future of life sciences and technology. |
|
INDUSTRY EVENTS |
|
Upcoming Events & Opportunities |
|
|
Betting on Biotech
Join fellow professionals from biotech, pharma, and medical device industries for an energizing evening of conversation, connection, and community.
July 24th | Dallas, TX |
|
|
The Future of Cancer Screening: MCED Updates from GRAIL
Join GRAIL for a conversation about advancements in multi-cancer early detection. They will provide updates on their clinical validation program, and review the latest efforts to establish timely, equitable access with policymakers.
July 29th | Online |
|
|
Reconnecting: The Future of Work, Together — A Networking Event for Life Sciences Professionals
Join Bhiant for an in-person networking event tailored for remote and hybrid professionals in biotech, pharma, and medical devices—an opportunity to connect with peers, exchange insights, and build meaningful relationships in a changing world of work.
July 29th | Arlington, TX |
|
|
DFW Startup Week 2025
Join DFW Startup Week, which brings together entrepreneurs and change-makers for a week-long experience. This event is described as the largest entrepreneurial event in North Texas, where they exchange ideas, collaborate, and grow alongside the 10th largest startup ecosystem in the US.
August 3rd - 7th | Dallas, TX |
|
|
DFW Startup Week - Tacos & Tech Talk
Join TechFW for breakfast and a hands-on workshop with Ned Meagher, Senior Partner at Carter, DeLuca & Farrell LLP. With 26+ years of experience in patent, trademark, and copyright prosecution, litigation, licensing, and IP strategy, Ned will guide you through the essentials of protecting—and monetizing—your innovations.
August 7th | Fort Worth, TX |
|
|
Rose Gala 2025
Join To Cure a Rose for the Rose Gala — an inspiring and unforgettable evening in support of To Cure A Rose Foundation. Set against the stunning backdrop of the Omni Barton Creek Resort, this exclusive event brings together elegance, entertainment, and purpose.
August 9th | Austin, TX |
|
|
Q3 2025 BHIANT Quarterly Meeting
Join BHIANT for their second quarterly meeting of 2025. Meet with other industry leaders and collaborate to tackle pressing challenges, redefine shared goals, and strengthen the biotech and healthcare ecosystem across North Texas.
August 19th | Dallas, TX |
|
|
Presents
2025 Talent Network Meet & Greet - Arlington
Join BioNTX for the Talent Network Meet & Greet in Arlington, where job seekers can connect with others in their field, share insights to grow their network, and meet with Catapult Solutions Group, a staffing firm that can support their job search & help advance their career journey.
August 20th | Arlington, TX |
|
|
Presents
2025 Talent Network Meet & Greet - Dallas
Join BioNTX for the Talent Network Meet & Greet in Dallas, where job seekers can connect with others in their field, share insights to grow their network, and meet with Catapult Solutions Group, a staffing firm that can support their job search & help advance their career journey.
August 21st | Dallas, TX |
|
|
2025 iC³ Life Science & Healthcare Innovation Summit
The annual iC³ Life Science Summit serves as North Texas’ premier platform for the bioscience community, uniting industry and academic leaders to discuss breakthrough research, share insights, and connect over cutting-edge technologies shaping the future of healthcare.
September 16th - 17th | Dallas, TX |
|
Thank you for your Membership & Support! "Creativity is piercing the mundane to find the marvelous." - Bill Moyers |
|
|
July 15, 2025 |
|
